Warby Parker Inc. (WRBY)

USD 23.71

(-2.39%)

Operating Expenses Summary of Warby Parker Inc.

  • Warby Parker Inc.'s latest annual operating expenses in 2023 was 437.22 Million USD , down -6.07% from previous year.
  • Warby Parker Inc.'s latest quarterly operating expenses in 2024 Q2 was 110.59 Million USD , down -3.92% from previous quarter.
  • Warby Parker Inc. reported a annual operating expenses of 452.26 Million USD in annual operating expenses 2022, down -1.98% from previous year.
  • Warby Parker Inc. reported a annual operating expenses of 461.41 Million USD in annual operating expenses 2021, up 60.45% from previous year.
  • Warby Parker Inc. reported a quarterly operating expenses of 115.1 Million USD for 2024 Q1, up 5.95% from previous quarter.
  • Warby Parker Inc. reported a quarterly operating expenses of 108.63 Million USD for 2023 Q4, down -3.43% from previous quarter.

Annual Operating Expenses Chart of Warby Parker Inc. (2023 - 2019)

Historical Annual Operating Expenses of Warby Parker Inc. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 437.22 Million USD -6.07%
2022 452.26 Million USD -1.98%
2021 461.41 Million USD 60.45%
2020 287.56 Million USD 27.94%
2019 224.77 Million USD 0.0%

Peer Operating Expenses Comparison of Warby Parker Inc.

Name Operating Expenses Operating Expenses Difference
Alcon Inc. 4.2 Billion USD 89.61%
AptarGroup, Inc. 814.37 Million USD 46.312%
Baxter International Inc. 5.27 Billion USD 91.707%
Becton, Dickinson and Company 6.04 Billion USD 92.77%
Bausch + Lomb Corporation 2.37 Billion USD 81.583%
Haemonetics Corporation 526.66 Million USD 16.983%
Envista Holdings Corp 1.15 Billion USD 62.004%
ResMed Inc. 1.36 Billion USD 68.048%
Teleflex Incorporated 1.08 Billion USD 59.674%
West Pharmaceutical Services, Inc. 454 Million USD 3.696%